• 1. School of Nursing, Nanjing Medical University, Nanjing, Jiangsu 211166, P. R. China;
  • 2. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P. R. China;
LIU Kouying, Email: liuky188@126.com
Export PDF Favorites Scan Get Citation

Objective  To analyse the content and structure of the health management policy text for chronic obstructive pulmonary disease (COPD) in China, and to provide a reference for the optimization and improvement of subsequent relevant policies. Methods  We searched for relevant policy documents on COPD health management at the national level from January 2017 to December 2023, constructed a two-dimensional analysis framework for policy tools and chronic disease health management processes, coded and classified policy texts, and used content analysis method to analyze policy texts. Results  Twenty-four policy texts were included. There were 183 codes for policy tool dimension, with supply based, environmental based, and demand based tools accounting for 43.72%, 47.54%, and 8.74%, respectively. There were 124 codes for the dimension of health management processes, with health information collection and management accounting for 12.10%, risk prediction accounting for 14.52%, intervention and treatment accounting for 66.13%, and follow-up and effectiveness evaluation accounting for 7.26%. Conclusions  At present, the proportion of policy tools related to the management of COPD in China needs to be dynamically adjusted. Environmental tools should be appropriately reduced, the internal structure of supply tools should be optimized, the driving effect of demand tools should be comprehensively enhanced, the coupling of COPD health management processes should be strengthened, and the relevant policy system and overall quality should be continuously improved.

Citation: QU Mingye, LIU Kouying, TANG Ting, SUN Xiaohui, CHEN Yuanyuan, YANG Lan, CAI Hao. Analysis of policies related to health management of chronic obstructive pulmonary disease in China from the perspective of policy tool. West China Medical Journal, 2024, 39(4): 535-540. doi: 10.7507/1002-0179.202310233 Copy